|
Beurs gesloten -
Nasdaq
22:00:00 02-10-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 10,50 USD | -6,75% |
|
-10,79% | -33,04% |
| 01/10 | Monte Rosa Therapeutics maakt positieve resultaten bekend van fase 1-onderzoek GFORCE-1 naar MRT-8102 | CI |
| 01/10 | Monte Rosa Therapeutics, Inc. - Special Call |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6,75% | -10,79% | -24,13% | -56,63% | -33,04% | +35,66% | +147,64% | -45,08% | - | 896 mln. | |
| +4,16% | +3,04% | +8,78% | +34,82% | +84,62% | +49,37% | +94,17% | +9,52% | - | 74,16 mld. | |
| -3,11% | -3,53% | -8,75% | -1,85% | +13,76% | +20,19% | +79,01% | +218,02% | +5.336,00% | 57,39 mld. | |
| +0,89% | -0,63% | -0,28% | -1,50% | +5,17% | +2,17% | +35,99% | -18,05% | +204,41% | 47,64 mld. | |
| +0,36% | +0,81% | -1,61% | +9,19% | +159,44% | +342,39% | +748,97% | +622,52% | - | 44,29 mld. | |
| -0,96% | -4,50% | -3,57% | +24,72% | +14,55% | +24,96% | +31,45% | +8,23% | +227,72% | 42,5 mld. | |
| -0,20% | -0,77% | -0,05% | +20,30% | +17,86% | +4,13% | +111,69% | +1,20% | +1.065,97% | 40,71 mld. | |
| -0,54% | +2,93% | -2,92% | -0,54% | +5,93% | +9,31% | +54,06% | -10,44% | +140,38% | 30,97 mld. | |
| +1,28% | +3,46% | +13,96% | +46,16% | +75,73% | +31,55% | +28,79% | -53,10% | - | 28,53 mld. | |
| +0,05% | -1,64% | -6,61% | -0,66% | +1,79% | -8,14% | -12,10% | -61,07% | - | 24,34 mld. | |
| +2,33% | -5,69% | -12,01% | -0,43% | -36,15% | -29,29% | +360,12% | +319,95% | +663,19% | 24,27 mld. | |
| -2,42% | -0,88% | +4,25% | +20,79% | +11,35% | +7,48% | -7,31% | -17,11% | +99,38% | 20,32 mld. | |
| +0,23% | -3,14% | +1,38% | +7,51% | +6,73% | +12,58% | +148,04% | +213,04% | +1.900,23% | 16,73 mld. | |
| -0,43% | +0,87% | -11,07% | -7,36% | +174,96% | +131,18% | +355,27% | +1.692,64% | +635,44% | 15,16 mld. | |
| +0,25% | +1,01% | -15,78% | -16,99% | - | - | - | - | - | 14,96 mld. | |
| +0,43% | -3,23% | +2,94% | +7,93% | +19,97% | +19,01% | +43,19% | -28,54% | +82,14% | 14,63 mld. | |
| +0,78% | +0,40% | -1,05% | +4,55% | +33,22% | +45,65% | +168,34% | +177,52% | +369,37% | 14,47 mld. | |
| -0,89% | +2,81% | -4,57% | -10,60% | +19,33% | -16,65% | +500,00% | - | - | 14,38 mld. | |
| +1,17% | -0,90% | +0,59% | +25,79% | +45,47% | +63,64% | +52,01% | -27,17% | +249,33% | 13,85 mld. | |
| +0,17% | -9,86% | +18,59% | +27,14% | +29,77% | -16,40% | - | - | - | 13,83 mld. | |
| Gemiddelde | -0,16% | -1,82% | -2,10% | +6,62% | +34,23% | +38,36% | +163,30% | +176,59% | +914,46% | 27,7 mld. | |
| Gewogen gemiddelde per kap. | +0,34% | -1,25% | -0,58% | +12,37% | +41,34% | +46,99% | +156,22% | +147,55% | +1.308,03% |
- Beurs
- Aandelen
- Koers GLUE
- Sector Monte Rosa Therapeutics, Inc.
Kies jouw editie
Alle financiële informatie op nationaal niveau
